M. Kulyk & Associates, LLC Amgen Inc Transaction History

M. Kulyk & Associates, LLC

$446 Million
Q4 2024

A detailed history of M. Kulyk & Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 22,416 shares of AMGN stock, worth $6.94 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

22,416

Previous 22,560 0.64%

Holding current value

$6.94 Million

Previous $7.27 Million 19.63%

% of portfolio

1.31%

Previous 1.48%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$258.78 - $328.31 $37,264 - $47,276	-144 Reduced 0.64%	22,416 $5.84 Million
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $72,704 - $79,284	-235 Reduced 1.03%	22,560 $7.27 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $149,504 - $181,687	569 Added 2.56%	22,795 $7.12 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $45,170 - $54,526	-168 Reduced 0.75%	22,226 $6.32 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $241,380 - $272,306	-944 Reduced 4.04%	22,394 $6.45 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $119,164 - $147,945	545 Added 2.39%	23,338 $6.27 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $122,776 - $145,181	573 Added 2.58%	22,793 $5.06 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $165,504 - $201,721	733 Added 3.41%	22,220 $5.37 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $14,428 - $18,333	63 Added 0.29%	21,487 $5.64 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $90,008 - $101,513	401 Added 1.91%	21,424 $4.83 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $82,594 - $91,912	358 Added 1.73%	21,023 $5.12 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $1.14 Million - $1.26 Million	-5,203 Reduced 20.11%	20,665 $5 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $325,964 - $373,036	1,639 Added 6.76%	25,868 $5.82 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $336,023 - $393,692	1,583 Added 6.99%	24,229 $5.15 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $466,225 - $517,243	1,996 Added 9.67%	22,646 $5.52 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $1.4 Million - $1.63 Million	6,296 Added 43.86%	20,650 $5.14 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $3.11 Million - $3.7 Million	14,354 New	14,354 $3.3 Million

Others Institutions Holding AMGN

# of Institutions

3,166

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.

Account

M. Kulyk & Associates, LLC Amgen Inc Transaction History